Cutaneous ulcers in association with sprue-like enteropathy secondary to Losartan

Francis Essien; Juakiem Wassem; Joshua Tate; Jared Roberts

doi:10.1002/ccr3.4645

Cutaneous ulcers in association with sprue-like enteropathy secondary to Losartan

Clin Case Rep. 2021 Aug 16;9(8):e04645. doi: 10.1002/ccr3.4645. eCollection 2021 Aug.

Authors

Francis Essien¹, Juakiem Wassem^{1

2}, Joshua Tate^{1

3}, Jared Roberts^{1

4}

Affiliations

¹ Department of Internal Medicine Keesler Medical Center Keesler Air Force Base Keesler AFB MS USA.
² Department of Gastroenterology Keesler Medical Center Keesler Air Force Base Keesler AFB MS USA.
³ Department of Endocrinology Keesler Medical Center Keesler Air Force Base Keesler AFB MS USA.
⁴ Department of Dermatology Keesler Medical Center Keesler Air Force Base Keesler AFB MS USA.

Abstract

Losartan is an angiotensin II receptor blocker (ARB) which may cause severe sprue-like enteropathy (SLE) with skin manifestation. Clinicians should be informed of this side effect and its reversibility after cessation of the drug.

Keywords: Losartan; angiotensin II receptor blocker; chronic diarrhea; sprue‐like enteropathy.

Publication types

Case Reports